Navigation Links
KaloBios Provides Clinical Update and Reports Second Quarter Financial Results
Date:8/7/2014

ct management's current knowledge, assumptions, judgment and expectations regarding future performance or events. Although management believes that the expectations reflected in such statements are reasonable, they give no assurance that such expectations will prove to be correct and you should be aware that actual results could differ materially from those contained in the forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties including, but not limited to, the potential timing and outcomes of clinical studies of KB001-A and KB004 undertaken now or in the future; the ability of the company to timely source adequate supply of its development products from third party manufacturers on whom the company depends; the potential, if any, for future development of KB003; the company's limited cash reserves and its ability to obtain additional capital on acceptable terms, or at all, including the additional capital which will be necessary to complete the clinical trials that the company has initiated or plans to initiate; the company's ability to successfully progress, partner or complete further development of its programs; the uncertainties inherent in clinical testing; the timing, cost and uncertainty of obtaining regulatory approvals; the company's ability to protect the company's intellectual property; competition; changes in the regulatory landscape or the imposition of regulations that affect the company's products; and other factors listed under "Risk Factors" in the company's most recent quarterly report on Form 10-Q filed with the Securities and Exchange Commission on May 8, 2014, the Annual Report on Form 10-K filed on March 13, 2014, and the company's other filings with the Securities and Exchange Commission.

All forward-looking statements are expressly qualified in their entirety by this cautionary notice. You are cautioned not to place undue reliance on any forward-looking statements, which s
'/>"/>

SOURCE KaloBios Pharmaceuticals, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. KaloBios Provides Update on KB001-A Partnership and Clinical Status
2. KaloBios Appoints Harry Lam, Ph.D. as Head of Manufacturing
3. U.S. FDA Grants Orphan Drug Designation for KaloBios KB001-A in Treatment of Cystic Fibrosis Patients
4. KaloBios Elects Laurie Smaldone Alsup, M.D. to Board
5. KaloBios to Present at Leerink Swann Rare Disease Roundtable
6. KaloBios Pharmaceuticals, Inc. Prices Public Offering of Common Stock
7. Herb C. Cross to Join KaloBios as Chief Financial Officer
8. KaloBios KB001 Anti-Pseudomonas Antibody Study Published in Pediatric Pulmonology
9. KaloBios to Present at Stifel Healthcare Conference 2013
10. KaloBios Reports First Quarter 2013 Financial Results
11. KaloBios to Present at Needham Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 23, 2015 Gem Pharmaceuticals announced today that the ... into the Company,s Phase 2 clinical trial.  This open-label ... lead compound, GPX-150 (an investigational medication), in approximately 30 ... Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO ...
(Date:1/23/2015)... 23, 2015 Tianyin Pharmaceutical Inc. (NYSE Amex: ... the development and sale of patented biopharmaceutical medicine, modernized ... ingredients (API) today announced the business and development progress ... 1. Following the September 2014 JCM application (No. ...
(Date:1/22/2015)... Colo. , Jan. 22, 2015  BiOptix is pleased ... as Vice President of Chemistry and Biochemistry. Scott joins ... Pharmaceuticals, AstraZeneca Pharmaceuticals, and Amgen throughout the course of ... development. "Scott is a nationally recognized thought ...
Breaking Medicine Technology:Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2TPI's JCM Updates on Import Registration for International Clients 2TPI's JCM Updates on Import Registration for International Clients 3TPI's JCM Updates on Import Registration for International Clients 4BiOptix Expands Leadership Team with the Appointment of Dr. Scott Klakamp as Vice President of Chemistry and Biochemistry 2
... Biopharmaceutical Services, Inc. announced today that the U.S. ... for an Electronic Submissions Gateway (ESG) to the ... clients a validated, direct electronic path for IND ... BLA (Biologic License Application) submissions and builds upon ...
... Gamma Knife® Perfexion™ earned the number one ranking in the ... in KLAS Awards: Medical Equipment & Infrastructure* report. Perfexion ... In the report, Perfexion scored 92.9 out of ... again. On a 1 to 9 scale, Perfexion received an ...
Cached Medicine Technology:Laureate's Electronic Submission Gateway Approved 2Elekta's Leksell Gamma Knife Perfexion is Ranked 2011's Best in KLAS for Radiation Therapy 2Elekta's Leksell Gamma Knife Perfexion is Ranked 2011's Best in KLAS for Radiation Therapy 3
(Date:1/22/2015)... LunaDress, with its top dressmaking technologies, has been ... business is showing its latest designs of wedding dresses and ... the company’s CEO, all the fresh new products are designed ... up to 80% off. All the clothes from LunaDress follow ...
(Date:1/22/2015)... Padre Murphy's and Owner Tom Boyle in ... Player Health Alliance (PPHA). The PPHA's passion for others' ... including NFL greats, treated for obstructive sleep apnea (OSA) has ... the cause in the valley. The most recent plans for ...
(Date:1/22/2015)... Blue Cross and Blue Shield of Minnesota (Blue ... means to “Live Fearless.” , The “Faces of ... stories about how they or someone they know has faced ... in the moment. By telling these types of stories through ...
(Date:1/22/2015)... January 22, 2015 A new white ... experience and person-centeredness in the long-term care environment as ... across the continuum. The paper, “The Power of Person-Centeredness ... perspectives and practices of the patient, resident and family ...
(Date:1/22/2015)... Carinsurancesavings.biz has released a new blog post presenting ... . , Purchasing an accidental death and dismemberment rider ... type of rider provides benefits if the insured dies in ... lesser form of life insurance. , AD&D is not ...
Breaking Medicine News(10 mins):Health News:LunaDress Shows The Latest Styles Of Wedding Dresses In 2015 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2
... website to improve navigation, functionality and user-friendliness. The new website ... but with better design and navigation, users can now access ... ... Neptune Beach, FL (PRWEB) May 18, ...
... Most Hispanics agree that the health of the entire ... their ownRIDGEFIELD, Conn., May 18 The economic downturn ... in the Hispanic community, with parents prioritizing their children,s ... Hispanics consider it equally important for parents to take ...
... States District Court issued a decision and order Friday ... attempt to prevent Ted Karkus, Mark Burnett, John ... McCubbin ("the Shareholder Nominees") from continuing their efforts to allow ... current board. The Federal Court,s decision followed ...
... /PRNewswire-Asia-FirstCall/ -- Emerald Dairy, Inc.,(OTC Bulletin Board: EMDY), a leading ... soybean products in China, today announced,results for the first fiscal ... Financial Highlights for the First Quarter, -- ... essentially breakeven in the ...
... on frequency of resistance development and safety presented ... and Infectious Diseases (ECCMID)SAN DIEGO, May 18 ... drugs for the treatment of serious bacterial infections, ... torezolid (TR-701), a novel antibiotic that is a ...
... Sciences, Inc. (OTC Bulletin Board: DSCI), a provider ... first quarter ended March 31, 2009. For the quarter, ... million in the first quarter 2008. The sales decrease of ... a significant weakening in the Canadian dollar and inventory rationalization ...
Cached Medicine News:Health News:International Student Insurance Announces Website Redesign 2Health News:New Research Finds Recession Has Greater Impact on Health of Parents than Children with Specific Findings on Hispanics 2Health News:New Research Finds Recession Has Greater Impact on Health of Parents than Children with Specific Findings on Hispanics 3Health News:Judge Rejects Quigley's Claims - Karkus Director Candidates Prevail in Federal Court 2Health News:Judge Rejects Quigley's Claims - Karkus Director Candidates Prevail in Federal Court 3Health News:Judge Rejects Quigley's Claims - Karkus Director Candidates Prevail in Federal Court 4Health News:Judge Rejects Quigley's Claims - Karkus Director Candidates Prevail in Federal Court 5Health News:Judge Rejects Quigley's Claims - Karkus Director Candidates Prevail in Federal Court 6Health News:Judge Rejects Quigley's Claims - Karkus Director Candidates Prevail in Federal Court 7Health News:Emerald Dairy Inc. Reports Record Earnings For First Quarter 2009 2Health News:Emerald Dairy Inc. Reports Record Earnings For First Quarter 2009 3Health News:Emerald Dairy Inc. Reports Record Earnings For First Quarter 2009 4Health News:Emerald Dairy Inc. Reports Record Earnings For First Quarter 2009 5Health News:Emerald Dairy Inc. Reports Record Earnings For First Quarter 2009 6Health News:Trius Presents New Data on Torezolid Antibiotic for Treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections 2Health News:Derma Sciences Reports First Quarter 2009 Results 2Health News:Derma Sciences Reports First Quarter 2009 Results 3Health News:Derma Sciences Reports First Quarter 2009 Results 4Health News:Derma Sciences Reports First Quarter 2009 Results 5Health News:Derma Sciences Reports First Quarter 2009 Results 6
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: